MEDICLIN Concludes Profitable 2024 Financial Year

Offenburg-based MEDICLIN AG reported a successful financial year for 2024, with sales reaching EUR 748.8 million, a 2.6% increase from the previous year. This marks the highest sales in the company's history. The group’s operating result was EUR 53.5 million, significantly improved from the previous year, which was impacted by goodwill amortisation in the acute segment.

The core focus on rehabilitation and strategic acquisitions, such as the Reha-Klinik am Sendesaal, played a key role in these results. Adjusted figures show a consolidated sales growth of over 8% and a group operating result increase of over 70%.

In the post-acute segment, sales rose by 7.6% to EUR 485.4 million. Although the acute segment saw a drop due to asset sales, adjustments indicate an 8.7% increase. Other segments, like nursing care and services, also saw notable growth.

Looking ahead to 2025, MEDICLIN is optimistic, projecting sales growth between 2.0% and 5.0% and a targeted group EBIT of EUR 53.0 to 64.0 million.